Not Yet RecruitingPhase 4ketamine

Efficacy of Propofol Combination With Either Ketamine, Dexmedetomidine or Midazolam for Sedation During Upper Gastrointestinal Endoscopic Procedures

Sponsored by Ain Shams University

NCT ID
NCT07190612
Target Enrollment
75 participants
Start Date
2025-12
Est. Completion
2026-03

About This Study

The investigators are comparing the efficacy of three different sedative agents in gastrointestinal endoscopic procedures.

Conditions Studied

Upper Gastrointestinal EndoscopyAnesthesia

Interventions

  • Dexmedetomidine and propofol
  • Midazolam and propofol
  • ketamine and propofol

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Both male and female patients aged between 18 and 65 years
* Patients who are scheduled for elective upper gastrointestinal endoscopic procedures with sedation
* Patients who are classified as ASA (American Society of Anesthesiologists) I and II

Exclusion Criteria:

* Patient's refusal to participate
* Respiratory compromise as patients with respiratory failure or with active chest conditions, e.g., bronchial asthma or pneumonia
* Cardiovascular compromise including heart failure and shocked patients
* Severe uncontrolled hematemesis with shock or risk of aspiration.
* Patients who are allergic or have any contraindications to any of the used drugs.
* Patients who have a chronic neuropsychiatric disorder or are on a neuropsychiatric drug.
* Patients on long-term sedative medication have a history of drug or alcohol abuse.
* Pregnancy and lactation

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Hazem M Hazem Mohamed Sabry, Specialist, MMsc.
CONTACT
00201006948041hazem.mohamed@med.asu.edu.eg
Ahmad Mostafa, PhD
CONTACT
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source